Liver cancer is the 3rd leading cause of cancer death globally, with China bearing 40% of cases due to high HBV prevalence. Key projections:
| Risk Factor | 2022 Share | 2050 Projection | Change |
|---|---|---|---|
| HBV-related | 39% | 37% | ↓ |
| HCV-related | 29% | 26% | ↓ |
| Alcohol-related | 19% | 21% | ↑ |
| MASLD/MASH-related | 8% | 11% | ↑38% |
Data Source: The Lancet Commission Report
Viral Hepatitis
HBV causes 39% of global HCC; HCV causes 29%
Prevention: Universal adult HBV screening + 90% vaccination coverage in high-burden regions
Alcohol Consumption
Responsible for 19% of cases (rising to 21% by 2050)
Policy Solutions: Minimum unit pricing, health warning labels, advertising bans
Obesity & MASLD/MASH
Affects 1.8 billion people globally; MASH-driven HCC to rise 38% by 2050
Screening: Liver injury tests for high-risk groups (diabetes, obesity, CVD)
✅ Vaccination & Screening
Mandatory HBV immunization in high-prevalence countries
Targeted HCV testing in endemic areas
✅ Lifestyle Interventions
Medical counseling on nutrition/exercise for MASLD patients
Sugar taxes + clear "high-fat/salt/sugar" food labeling
✅ Early Detection
Prioritize ultrasound surveillance for high-risk groups
Integrate liver health into diabetes/obesity management
✅ Global Equity
Bridge East-West gaps in treatment access
Scale palliative care integration
| Scenario | 2022 Baseline | 2050 Projection | Prevention Potential |
|---|---|---|---|
| Annual cases | 870,000 | 1.52 million | — |
| Annual deaths | 760,000 | 1.37 million | — |
| With 2–5% annual reduction | — | 9–17 million cases prevented | 8–15 million lives saved |
"Unlike other cancers, liver cancer has clearly identifiable risk factors. Controlling HBV, alcohol, and MASLD could prevent most cases."
— Prof. Lin Chen, Chinese University of Hong Kong
"MASLD is the fastest-growing cause of HCC. We must screen high-risk groups before irreversible damage occurs."
— Prof. Hashem B El-Serag, Baylor College of Medicine
Full Report: The Lancet DOI: 10.1016/S0140-6736(25)01134-1
Commission Chairs: Prof. Jian Zhou (Fudan University), Prof. Valérie Paradis (Beaujon Hospital)
Headline Optimization: Use "60% preventable" + "global action" in H1/H2
Visual Content:
Infographic: 3 risk factors + prevention efficacy
Interactive map: Country-specific HCC projections
Target Audiences:
Healthcare policymakers (highlight cost-saving data)
At-risk patients (MASLD/diabetes management tools)
Pharma/medtech (early detection device partnerships)